Company intelligence / Profile preview

Deerfield Generics

New York City, New York, United States

Ownership: Private
Employees: ~178
Development stage: Other

Overview

Deerfield Management is a healthcare-focused investment firm specializing in public and private investments across biotechnology, pharmaceuticals, medical technologies, and services. It manages over $15-16 billion in assets and engages in significant academic collaborations.

Industry: Investors

Partnerships

Broad InstituteHarvard UniversityWashington UniversityNovo Nordisk (via portfolio company Neomorph)AMR Action Fund (via portfolio company Elion Therapeutics)

Beyond the preview

Go deeper on Deerfield Generics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Deerfield Generics.

Explore the full profile